Antoine CARPENTIER
University Hospital of Besançon · APHP- Hôpital Saint Louis · Assistance Publique - Hôpitaux de Paris
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Antoine CARPENTIER as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:22 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07347210 · Evaluation of UCPVax Vaccine +/- Pembrolizumab Combined With Standard Treatment as Adjuvant Therapy in Patients With Unmethylated MGMT GlioblastomaCentre Hospitalier Universitaire de Besancon · not yet recruiting · Primary Glioblastoma · principal investigator
- Ph1/Ph2NCT06622434 · New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a StudyAssistance Publique - Hôpitaux de Paris · recruiting · Newly Diagnosed Glioblastoma · study chair
- Ph3NCT01805453 · Angiotensin II Receptor Blockers, Steroids and Radiotherapy in GlioblastomaAssistance Publique - Hôpitaux de Paris · completed · Newly-diagnosed Glioblastoma · principal investigator
- N/ANCT01363557 · Assess the Efficacy of Whole Brain Radiation Therapy in Lung Cancer Patients With Brain MetastasisAssistance Publique - Hôpitaux de Paris · terminated · EGFR-mutated Lung Adenocarcinoma, Brain Metastasis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:22 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in glioblastoma, ranked by citations from NIH iCite, fetched 2026-11-12 11:22 UTC. The ranking covers the 200 most relevant of 20 PubMed records, and a shared surname and initials can bring in a namesake. All 20 on PubMed
- Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma.N Engl J Med · 20142,045 citationsRCR 64.2
- Clinical trial of blood-brain barrier disruption by pulsed ultrasound.Sci Transl Med · 2016595 citationsRCR 22.5
- 482 citationsRCR 43.2
- Randomized phase II trial of erlotinib versus temozolomide or carmustine in recurrent glioblastoma: EORTC brain tumor group study 26034.J Clin Oncol · 2009456 citationsRCR 10.5
- Phase III study of enzastaurin compared with lomustine in the treatment of recurrent intracranial glioblastoma.J Clin Oncol · 2010408 citationsRCR 10.1
- 221 citationsRCR 6.7
- 220 citationsRCR 23.5
- Phase 1 trial of a CpG oligodeoxynucleotide for patients with recurrent glioblastoma.Neuro Oncol · 2006172 citationsRCR 3.8
- Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study.Neuro Oncol · 2010162 citationsRCR 3.7
- 118 citationsRCR 17.3